Case Study: a mid-sized clinical-stage biopharmaceutical company strengthens BLA inspection readiness with WCG Clinical's mock inspection consulting

Mid-sized Clinical-stage Biopharmaceutical Company completes 4-day mock inspection with WCG Clinical

The customer, a mid-sized clinical-stage biopharmaceutical company, faced the challenge of preparing for a regulatory inspection ahead of a critical Biologics License Application (BLA) filing. To ensure inspection readiness and identify potential gaps, they engaged WCG Clinical's Avoca consulting group for a mock inspection service.

WCG Clinical executed a multi-day, on-site mock inspection focused on FDA standards, delivered a detailed report, and led a strategy session to prioritize findings. This was followed by remediation assistance. The solution provided clear, actionable findings that the company used to rectify issues prior to their filing. The customer reported that the BLA submission was successful, crediting the mock inspection process with helping them identify and remedy problems beforehand.